Bottom line
What is MDSAX's expense ratio?
MDSAX's expense ratio is 0.8%, or about $80 a year on every $10,000 invested. That is more expensive than 81% of short-term bond funds we track (median 0.47%). This share class also charges a front-end sales load of up to 2%, taken from your investment when you buy. Its expense ratio includes a 0.25% 12b-1 marketing fee.
Updated Nov 26, 2025
MDSAX fee table
| Net expense ratio | 0.8% |
|---|---|
| Gross expense ratio | 1.09% |
| Management fee | 0.3% |
| 12b-1 (distribution) fee | 0.25% |
| Other expenses | 0.54% |
| Fee waiver / reimbursement | -0.29% |
| Max front-end sales load | 2% |
| Max deferred sales charge | 0% |
Source: Fund prospectus fee table, filed Nov 26, 2025
What MDSAX costs in dollars
The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| MDSAX | $280 | $511 | $761 | $1,477 |
Source: Fund prospectus expense example
The long-run cost of fees
On $100,000 growing at 6% a year for 20 years, a 0.8% expense ratio costs roughly $45,100 in lost growth, versus about $27,300 for the median short-term bond fund (0.47%).